Skip to Main Content

Jennifer Miller, PhD

Assistant Professor; Creative Director, Science for Good Initiative; Advisory Board Member, Global Healthcare Innovation Management Center, Graduate School of Business; Director, Good Pharma Scorecard Initiative; Board President, Bioethics International; Co-Director, Bioethics Masters Summer Intensive Program (with Llew Keltner); Yale Liaison, Working Group on: Bioethics of Data Science, Artificial Intelligence (AI) and Genomics Implementation Science Curriculum

Contact Information

Jennifer Miller, PhD

Mailing Address

  • Yale School of Medicine

    367 Cedar Street, Harkness 4th floor

    New Haven, CT, 06520

    United States

Appointments

Biography

Jennifer E. Miller, PhD, is an Assistant Professor in Yale School of Medicine and Director of the Good Pharma Scorecard initiative, an index that ranks new drugs and pharmaceutical companies on their ethics and and patient-centricity performance.

Dr. Miller's research explores the ethics of healthcare innovation, particularly how drugs are researched, developed, marketed, priced and made accessible to patients domestically and globally. She also works on the ethics of big data in healthcare, including informed consent, data-sharing, and ownership concerns.

Dr. Miller founded the nonprofit Bioethics International and is a member of The World Economic Forum, participating on their Futures Council, Biotechnology Council, and Personalized Medicine Council. Prior to joining Yale’s faculty, she was based at NYU School of Medicine, Duke University, and Harvard University. Her training is in physics, bioethics, business ethics, and regulatory governance.

Education & Training

  • BS
    Fordham University, Physics (2002)
  • Postdoctoral Fellowship
    Duke University
  • Postdoctoral Fellowship
    Harvard University

Activities

  • Pharmaceutical Industry Ethics and The Good Pharma Scorecard
    New York, United States 2020
  • What Makes Medical Data Sharing Ethical?
    New York, United States 2020
  • Clinical Trial Transparency and Data Sharing
    Broadstairs, United Kingdom 2020
  • Panel on Genomic Medicine Ethics
    San Diego, United States 2020
  • EHR Data Sharing: What Makes Data Sharing Ethical?
    Philadelphia, United States 2020
  • Bioethics and Controversial Trends in Healthcare Innovation
    New York, United States 2020
  • Responsible Data Sharing in Medicine and Clinical Research
    Montreal, Canada 2020
  • Non-Trial Preapproval Access to Investigational Medical Products
    New York, United States 2020
  • Discuss Ethical Standards for Clinical Research and the Responsibilities of the Life Sciences Industry
    Coral Gables, United States 2020
  • Transparency and Data Sharing in Clinical Trials: Ethics Standards and the Role of the Good Pharma Scorecard
    Ottawa, Canada 2019
  • Transparency in Health and Healthcare in the United States, Panel Presentation: Transparency and Data sharing in the Pharmaceutical Industry
    Cambridge, United States 2019
  • Ethics of Clinical Trials and Data Privacy
    Jerusalem, Israel 2019
  • Access to Emerging Therapies for Genetic Disorders
    Rochester, United States 2019
  • Responsible Clinical Trial Transparency and Data Sharing
    Philadelphia, United States 2019
  • Responsible Data Sharing
    Philadelphia, United States 2019
  • Brain Health and Performance Summit, Whose Data are They?
    Columbus, United States 2019
  • Inaugural Councils Meeting
    San Francisco, United States 2019
  • Progress Towards the Sustainable Development Goals
    Princeton, United States 2019
  • Ethics of Data-Sharing in Digital Medicine
    Boston, United States 2019
  • Roundtable on Data-Sharing in Medicine
    Santa Monica, United States 2019
  • Ethics of Big Data and AI in Radiology
    New York, United States 2019
  • Ethics of Big Data and AI in Radiology
    New York, United States 2019
  • Social Responsibility in Pharma
    Philadelphia, United States 2019
  • Breaking Barriers to Health Data Governance
    New York, United States 2019
  • Ethics of Federated Models
    New York, United States 2019
  • Solutions Approach to Data Privacy and Ethics
    New York, United States 2019
  • Establishing a Pharma Code of Ethics
    New York, United States 2019
  • Preventing the Cambridge Analytica of Health Data
    New York, United States 2019
  • Data-sharing Principles in Medicine
    New York, United States 2019
  • Ethics of Emerging Biotechnologies
    Dubai, United Arab Emirates 2018
  • Opening Keynote: The Ethics of Big Data in Healthcare. October 24, 2018
    New York, United States 2018
  • The Future of Health Summit, Panel on Innovation
    New York, United States 2018
  • Measuring Impact in Patient-Centered Drug Development
    New York, United States 2018
  • Blockchain as Pharma's Trust Catalyst
    New York, United States 2018
  • Deconstructing Clinical Trials: The Core of Drug Development and Company Valuations
    New York, United States 2018
  • Keynote, Ethics and Trust in Healthcare Innovation
    New York, United States 2018
  • Research Ethics Workshop
    New York, United States 2018
  • Promise and Reality of Clinical Trial Transparency and Data-sharing
    New York, United States 2018
  • Ethics and Governance and Healthcare Innovation
    New York, United States 2018
  • Clinical Trial Transparency and Data-sharing in Healthcare Innovation
    New York, United States 2018
  • Drug Accessibility and Pricing Symposium: Preserving Consumer Access in the Complex Pharmaceuticals Marketplace
    New York, United States 2018
  • Big Data and Ethics
    New York, United States 2018
  • Ethics of Big Data, Machine Learning and AI
    New York, United States 2018
  • Elevate Organizational and New Drug Clinical Trial Transparency Best Practices
    New York, United States 2018
  • Lecture on Pharmaceutical Ethics
    New York, United States 2017
  • Ethics, Transparency and Trust in Pharma and the Role of the Good Pharma Scorecard
    New York, United States 2017
  • Augmented Humans: Are Super Humans the New Reality?
    Dubai, United Arab Emirates 2017
  • Cybersecurity’s Accelerating Threat: The Impact of Evolving Technologies
    New York, United States 2017
  • Returning Lay Summaries to Trial Participants
    New York, United States 2017
  • Data-Sharing: Do We Measure Up?
    New York, United States 2017
  • The Need to Accelerate Therapeutic Development — Must Randomized Controlled Trials Give Way?
    New York, United States 2017
  • Transparency in Healthcare
    New York, United States 2017
  • The Intersecting Worlds of Researchers, Executives and Journalists
    New York, United States 2017
  • Ethics and Trust in the Pharmaceutical Industry
    New York, United States 2017
  • Cyber Security
    New York, United States 2017
  • Clinical Trial Transparency, Data-sharing, and the Good Pharma Scorecard
    New York, United States 2017
  • Healthcare Innovation Ethics
    New York, United States 2017
  • Clinical Data Disclosure and Transparency: Navigate Global Regulations, Data Sharing and Trial Registries, Explore Ethics and The Good Pharma Scorecard
    New York, United States 2017
  • Clinical Trial Transparency, Drug Development, and the Good Pharma Scorecard
    New York, United States 2016
  • Clinical Trial Transparency and Regulation Conference, Clinical Trial Data Sharing: Status & Benchmarking—Good Pharma Scorecard
    London, United Kingdom 2016
  • Ethics and Trust in Healthcare Innovation
    New York, United States 2016
  • Workshop on Ethical Issues in Marketing Pharmaceuticals in Emerging Health Systems
    New York, United States 2016
  • Working Together to Serve Patients
    New York, United States 2016
  • Caring for Vulnerable Populations: Cognitive Assessment, Ethical Considerations, and Health Policy
    New York, United States 2016
  • Ethics and Transparency in Healthcare Innovation
    New York, United States 2016
  • The Good Pharma Scorecard: Special Focus on Publications
    New York, United States 2016
  • Ethical Issues in Clinical Research
    New York, United States 2016
  • Pharmaceutical Strategy: Ethics and Reputational Hazards
    New York, United States 2016
  • Ethics and Governance of Healthcare Innovation and the Good Pharma Scorecard
    New York, United States 2016
  • Critical Issues in Emergency Medicine Antidotes in Society: Ethics, Capital, Regulation, Scientific Principle, Public Health, and the Public Good
    New York, United States 2016
  • Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
    New York, United States 2015
  • Lecture
    New York, United States 2015
  • Research Spotlight Presentation
    New York, United States 2015
  • Ethics and Trust in Healthcare Innovation: Could Ranking Pharmaceutical Companies and New Drugs on Clinical Trial Transparency Help?
    New York, United States 2015
  • Transparency and Data Sharing Roundtable
    New York, United States 2015
  • Lecture
    New York, United States 2015
  • The Ethics of Healthcare Innovation
    New York, United States 2015
  • Lecture
    New York, United States 2015
  • Lecture
    New York, United States 2015
  • Institutional Corruption in Medicine
    New York, United States 2015
  • Research Ethics
    New York, United States 2015
  • Ethics, Trust, Global Health and the Pharmaceutical Industry
    New York, United States 2015
  • Lecture
    New York, United States 2015
  • Bioethics and Trust in the Industry– Could Rating Help?
    New York, United States 2015
  • Ethics, Trust, Global Health and the Pharmaceutical Industry
    New York, United States 2015
  • Shining Light on Healthcare Innovation
    New York, United States 2015
  • Data-sharing in Clinical Trials
    New York, United States 2015
  • Institutional Corruption in Medicine
    New York, United States 2015
  • Ethics, Human Rights and Business
    New York, United States 2015
  • Transparency and Ethics in Healthcare Innovation
    New York, United States 2015
  • Corruption, Ethics and Governance in Biomedical Research
    New York, United States 2015
  • Adaptive Regulatory Strategies in Healthcare Innovation
    New York, United States 2014
  • Transparency and Trust in the Pharmaceutical Industry: Could Rating Help?
    New York, United States 2014
  • Ethics in the Pharmaceutical Industry: Could Rating Help?
    New York, United States 2014
  • Bioethics and Trust in the Industry– Could Rating Help?
    New York, United States 2014
  • Ethics and Trust in the Pharmaceutical Industry
    New York, United States 2014
  • Truth-telling and the Pharmaceutical Industry
    New York, United States 2014
  • Institutional Corruption in Big Pharma
    New York, United States 2014
  • Pharmaceutical Ethics: Industry Perspectives and a Strategy for Trustworthy Reform
    New York, United States 2014
  • Ethical standards in the Pharmaceutical Industry? Problems and a Strategy for Trustworthy Reform
    New York, United States 2014
  • Companies’ Global Health Footprint: Could Rating Help?
    New York, United States 2013
  • Globalization and the Market
    New York, United States 2013
  • Public Health Ethics
    New York, United States 2013
  • Bioethics and Trust in the Industry
    New York, United States 2013
  • Bioethics and Trust in the Industry
    New York, United States 2013
  • Ethical Standards in the Pharmaceutical Industry?
    New York, United States 2013
  • Ethical Standards in the Pharmaceutical Industry? Industry Perspectives and Reform Strategies
    New York, United States 2012
  • Pharmaceutical Ethics
    New York, United States 2012
  • The Ethics of Drug Development and Marketing
    New York, United States 2012
  • Ethical Standards for the Pharmaceutical Industry?
    New York, United States 2012
  • The Role of Virtue in Medicine,
    New York, United States 2011
  • Ethical Issues in Pediatric Emergency Mass Critical Care
    New York, United States 2011
  • Introduction to Bioethical Frameworks
    New York, United States 2011
  • Bioethical Issues in the Globalization of Clinical Research
    New York, United States 2011
  • Pharmaceutical Ethics
    New York, United States 2011
  • Genomics, Ethics and Industry Practice
    New York, United States 2011
  • Medical Diplomacy: Response to Environmental Disasters
    New York, United States 2011
  • Ethical Concerns in Biotechnology and Health Care Advances
    New York, United States 2011
  • Disaster Medicine
    New York, United States 2010
  • 15-year Review of the Implementation of the Beijing Declaration and Platform for Action (1995) and the Outcomes of the Twenty-third Special Session of the General Assembly (2000)
    New York, United States 2010
  • Lecture
    Tampa, United States 2010
  • Lecture
    Providence, United States 2010
  • Debate
    New York, United States 2010
  • Introduction to Ethical Frameworks and Clinical Decision-Making
    New York, United States 2009
  • Climate Change, Public Health and Emergency Preparedness,
    New York, United States 2009
  • Biotechnology in 20 Years: Privatization and Ethical Considerations
    New York, United States 2008
  • Balancing Autonomy and Community in Promotion of Human Dignity
    New York, United States 2008
  • New Dilemmas in Modern Medicine
    New York, United States 2008
  • Ethics of Pandemic Decision-making and Allocation of Medical Resources
    New York, United States 2008
  • Ethical Frameworks and Disaster Preparedness
    New York, United States 2008
  • New Ethical Dilemmas in Medicine
    New York, United States 2008
  • Bioethical Frameworks and Pandemic Preparedness
    New York, United States 2007
  • Did I Hasten My Patient’s Death?
    Bridgeport, United States 2007

Honors & Recognition

AwardAwarding OrganizationDate
Center for the Fourth Industrial Revolution, Precision Medicine CouncilAppointment to World Economic Forum2019
Biotechnology CouncilAppointment to World Economic Forum2018
Futures CouncilAppointment to World Economic Forum2017
Human Enhancement Working GroupAppointment to World Economic Forum2017
Ethical Issues in Global Population Health, Foundation BrocherFellow2014
United Nations Educational Social and Cultural Organization (UNESCO) Global Ethics ObservatoryAppointed2009

Professional Service

OrganizationRoleDate
Yale Pediatric Nephrology Residents Research Ethics Lecture (March 27, 2020)Lecturer2020
Yale Data Day, Cushing Whitney Medical Library Class: "Data and Privacy: Day of Data Series Panel Discussion, Yale Medical School Library (February 13, 2020)Participant2020
Yale Center For Clinical Investigation (YCCI), NCATS Clinical Translational Science Award (CTSA), Mount Sinai Curriculum for Bioethics Training in Data Science and AILead2020 - Present
Scientific American, Science for GoodEditor2020 - Present
Alexion Pharmaceuticals Ethics Committee, Expanded Access Program for Covid-Related Drugs and ALS ProgramCommittee Member2020 - Present
Consortia for Improving Medicine with Innovation and Technology (CIMIT), NIH-funded U54 Coordinating CenterNIH-funded U54 Coordinating Center focused on point of care testing SARS-CoV-2, national effort coordinated through NIH, directed at Yale by Michael K. Dempsey and at Harvard by Steven Schachter2020 - Present
Committee on Standards for Data Collection and Use, IEEEBoard Member2019 - 2020
Yale Law School Health Data Workshop Co-Chair with Chris Morten, Joe Ross, Jen Pinsoff, Amy KapczynskiCo-Chair2019
Yale Digital Medicine Symposium, Ethical Considerations in Digital Medicine, April 26, 2019Presenter/Speaker2019
Nature MedicineReviewer2019 - Present
BMC MedicineReviewer2019 - Present
The Journal of BioethicsReviewer2019 - Present
Yale Law School MFIA Clinic, Data-Sharing in Medicine, SupervisorLead2018 - 2019
Yale Law School, Center for Research and IntegrityMember2018 - 2019
Director’s Working Group on Ethical Considerations for Industry Partnership on Research to Help End the Opioid Crisis, NIHCommittee Member2018
New England Journal of Medicine (NEJM)Reviewer2018 - Present
The British Medical Journal (BMJ)Reviewer2018 - Present
World Economic ForumMember2017 - Present
New York University (NYU) School of Medicine, Pharmacy and Therapeutics CommitteeCommittee Member2016 - 2019
Pharmacy and Therapeutics Committee, NYU School of MedicineCommittee Member2016 - Present
NYU Electronic Medical Records (EMR) Working Group, New York UniversityTasked with developing new guidelines for incorporating clinical research into Epic2016 - Present
The Journal of the American Medical Association (JAMA) Internal MedicineReviewer2016 - Present
Institutional Review Board, Embryonic Stem Cell Research Oversight, New York University (NYU) School of MedicineCommittee Member2015 - 2019
Compassionate Use and Expanded Access Committee, Johnson and Johnson (J&J) and New NYU School of MedicineScientific Advisor2015 - 2017
Committee on Data Sharing and Transparency, Harvard University Multi-Regional Clinical Trials InitiativeBoard Member2015 - 2016
Journal of Evidence-based Medicine & Public HealthEditor2015 - 2016
Embryonic Stem Cell Research Oversight Committee, NYU School of MedicineCommittee Member2015 - Present
Journal of Clinical PharmacologyReviewer2015 - Present
Stem Cells Translation MedicineReviewer2015 - Present
Pragmatic Clinical Trials Initiative, Gatekeepers Workgroup, PCORI-NIH Collaboratory and National Patient-Centered Clinical Research NetworkBoard Member2014 - 2015
Pragmatic Clinical Trials Initiative, Vulnerable Subjects Workgroup, PCORI-NIH Collaboratory and National Patient-Centered Clinical Research NetworkBoard Member2014 - 2015
Public Library of Science (PLOS ONE)Reviewer2014 - Present
Criteria for Data Sharing Subgroup, Harvard University Multi-Regional Clinical Trials InitiativeCo-Chair2013 - 2014
Pharmaceutical Regulatory Affairs: Open Access, OMICS Publishing GroupReviewer2013 - Present
Law and Society Association, Institutional CorruptionCommittee Member2012 - 2015
Ethics Committee, Harvard University Multi-Regional Clinical Trials InitiativeCommittee Member2012 - 2014
American Society of Bioethics and HumanitiesMember2012 - Present
Advisory Board, Center for Policy and Emerging TechnologiesAdvisor2010 - 2015
Center for Policy and Emerging Technologies, Center for Policy and Emerging TechnologiesAdvisor2010 - 2015
Center for Policy and Emerging Technologies, Advisory BoardBoard Member2010 - 2015
Ethics Committee and IRB Workshop Director, Tampa General Hospital, Morsani College of Medicine, University of South FloridaDirector2010
Pediatric Emergency Mass Critical Care Taskforce, Steering Committee, Centers for Disease Control and Prevention (CDC)Committee Member2009 - 2011
Pediatric Emergency Mass Critical Care Taskforce, Ethics Committee, Centers for Disease Control and Prevention (CDC)Committee Member2009 - 2011
Pandemic and Emergency Preparedness Ethics Grand Rounds Director, St. Vincent’s Health System (Pennsylvania)Director2008
Pandemic and Emergency Preparedness Ethics Grand Rounds Director for the Department of Emergency Medicine, Hamot Hospital (Pennsylvania)Director2008
American Medical Association, National Disaster Life Support Education ConsortiumMember2007 - 2011
American Museum of Natural History, Junior Advisory CouncilCouncil Member2007 - 2011
ICU Rounds on End of Life Care Ethics, St. Vincent’s Medical Center (Connecticut)Lecturer2007
Medical Ethics Lecturer for Radiology and Transitional Year Residency Program, St. Vincent’s Medical Center (Connecticut)Lecturer2007
Medical Ethics Lecturer for Internal Medicine Department, St. Vincent’s Medical Center (Connecticut)Lecturer2007
Pandemic and Emergency Preparedness Ethics Hospital-Wide Grand Rounds, St. Vincent’s Medical Center (Connecticut)Lecturer2007
Bioethics InternationalPresident2006 - Present
Bioethics InternationalBoard Member2005 - Present
Bellevue Hospital, High School Pediatric Psychiatric Ward Volunteers, Volunteer DirectorDirector2004 - 2006

Departments & Organizations